BRIDGEWAY CAPITAL MANAGEMENT, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 167 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$519,000
+5.5%
14,8000.0%0.01%
-14.3%
Q4 2018$492,000
-34.0%
14,8000.0%0.01%0.0%
Q3 2018$745,000
-15.9%
14,8000.0%0.01%
-22.2%
Q2 2018$886,000
+30.7%
14,8000.0%0.01%
+28.6%
Q1 2018$678,000
+9.7%
14,800
-4.5%
0.01%0.0%
Q4 2017$618,0000.0%15,500
+0.3%
0.01%0.0%
Q3 2017$618,000
-15.5%
15,450
-8.8%
0.01%
-22.2%
Q2 2017$731,000
+38.2%
16,950
+0.3%
0.01%
+50.0%
Q1 2017$529,000
+88.9%
16,900
+52.3%
0.01%
+50.0%
Q4 2016$280,000
-53.7%
11,100
-77.8%
0.00%
-66.7%
Q1 2015$605,000
+45.8%
50,0000.0%0.01%
+33.3%
Q4 2014$415,000
-5.5%
50,000
-1.1%
0.01%
-18.2%
Q3 2014$439,000
-19.9%
50,550
+1.1%
0.01%
-21.4%
Q2 2014$548,000
+22.6%
50,0000.0%0.01%
+7.7%
Q1 2014$447,000
+18.6%
50,0000.0%0.01%
+18.2%
Q4 2013$377,000
+2.7%
50,0000.0%0.01%
-15.4%
Q3 2013$367,000
+14.0%
50,0000.0%0.01%0.0%
Q2 2013$322,00050,0000.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders